BioScience Health Innovations annual return on equity
2021
2022
2024
2025
BioScience Health Innovations Return on Equity (ROE) Growth & History (BHIC)
BioScience Health Innovations's return on equity was 55.53% for fiscal 2025.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 55.53% | +34.53 pp |
| 2024 | 2024-12-31 | 21.00% | — |
| 2022 · Aug 31 | 2022-08-31 | −10,394.50% | +186605.50 pp |
| 2021 | 2021-08-31 | −197,000.00% | — |
BioScience Health Innovations quarterly return on equity
Q1.20
Q2.20
Q1.21
Q2.21
Q1.22
Q2.22
Q3.22
Q1.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10.56% | −41.26 pp |
| Q1 2026 | 2026-03-31 | −14.54% | −55.24 pp |
| Q4 2025 | 2025-12-31 | −14.66% | −16.31 pp |
| Q3 2025 | 2025-09-30 | −0.51% | −20.61 pp |
| Q2 2025 | 2025-06-30 | 30.70% | −18.14 pp |
| Q1 2025 | 2025-03-31 | 40.70% | +139.46 pp |
| Q4 2024 | 2024-12-31 | 1.65% | +4168.43 pp |
| Q3 2024 | 2024-09-30 | 20.09% | — |
| Q2 2024 | 2024-06-30 | 48.84% | — |
| Q1 2024 | 2024-03-31 | −98.76% | — |
| Q4 2023 | 2023-12-31 | −4,166.78% | — |
| Q1 2023 · Nov 30 | 2022-11-30 | −145.06% | −98.35 pp |
| Q3 2022 · May 31 | 2022-05-31 | −151.29% | — |
| Q2 2022 · Feb 28 | 2022-02-28 | −27.23% | +1371.00 pp |
| Q1 2022 | 2021-11-30 | −46.71% | +8.91 pp |
| Q2 2021 | 2021-02-28 | −1,398.23% | −1192.68 pp |
| Q1 2021 | 2020-11-30 | −55.62% | −55.62 pp |
| Q2 2020 | 2020-02-29 | −205.55% | — |
| Q1 2020 | 2019-11-30 | 0.00% | — |
BioScience Health Innovations return on equity trends
Between the periods ended 2021-08-31 and 2025-12-31, BioScience Health Innovations's return on equity increased from −197,000.00% to 55.53%, a change of +197055.53 percentage points. The latest reported quarter, Q2 2026, shows −10.56%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations source filings ↗